Development of clinical pharmacy programs integrated into patient care pathways using adverse event risks

How a Patient Personalised Clinical Pharmacy Programme Can Secure Therapeutic Care in an Orthogeriatric Care Pathway (5P Project)?

“…The clinical pharmacy programme was developed and described by Hoegy et al 14 Briefly, a Delphi technique was used with surgeons, geriatricians, paramedics, and pharmacists involved in the orthogeriatric care pathway in order to define criteria for prioritization of patients based on adverse events, and to position clinical pharmacy activities at the most relevant steps of the pathway.…”

“…Most Common PI by DRP/Medication Categories Encountered in the Orthogeriatric Care(11)(12)(13)(14)(15)(16)(17)(18)(19)(20) All PI were exclusively made in acute care, except "DRP and medication categories" number 15, 17, 19 and 20 in which one to three PI were formulated in rehabilitation unit.…”

Implementation assessment of a patient personalized clinical pharmacy programme (5P project) into orthogeriatric care pathway

“…Yet, our HR eligibility criteria were not arbitrarily chosen but extracted from the results of a previous study. 14 Task assignment to pharmacy students or pharmacists was suboptimal. Other professionals, with an appropriate training, could have been involved to be more efficient and to prevent staff shortages (e.g.…”

“…Once the orthogeriatric pathway was selected, a preliminary study was performed in order to identify which clinical pharmacy activities should be performed, at which step of the care pathway they should be implemented, and which criteria should be used to stratify patients according to their risk of AE (high risk, HR, vs low risk, LR). 14 It is to be noted that another analysis was made to describe the clinical pharmacy activities performed by ward type and to evaluate their potential clinical impact. 15 The aim of the present study was to assess the implementation of clinical pharmacy activities in an orthogeriatric care pathway regarding medication error prevention, healthcare professionals' and patients' satisfaction, and the associated pharmaceutical workload.…”

“…Clinical pharmacists can ensure the continuity of patients’ drug management. Once the orthogeriatric pathway was selected, a preliminary study was performed in order to identify which clinical pharmacy activities should be performed, at which step of the care pathway they should be implemented, and which criteria should be used to stratify patients according to their risk of AE (high risk, HR, vs low risk, LR) 14 . It is to be noted that another analysis was made to describe the clinical pharmacy activities performed by ward type and to evaluate their potential clinical impact 15 .…”